Stratified Risk (95% Confidence Interval) of HPA-1a Alloimmunization and its Complications in At-Risk Populations
Population (n) . | ||||||
---|---|---|---|---|---|---|
HPA-1a | NK | Negative | Negative | Negative | Negative | Negative |
HLA-DRB34-1500101 | NK | NK | Positive | NK | Positive | Positive |
Anti–HPA-1a | NK | NK | NK | Negative | Positive at any time | Persistently positive antenatally |
Event | 25,379 | 387 | 123 | 341 | 46 | 32 |
HPA-1a negativity | 1:40 (36.7-42.8) | |||||
HPA-1a alloimmunization | 1:3474-150(282-451) | 1:8.4 (6.9-12.1) | 1:2.8 (2.3-3.7) | |||
Thrombocytopenic infant4-151 | 1:3364-150 (250-509) | 1:8.6‡(6.5-12.7) | 1:4.9 (3.6-7.6) | 1:21‡ (13.4-46.3) | 1:2.1 (1.6-3.0) | 1:1.8 (1.4-2.7) |
Severe thrombocytopenia4-153 | 1:11004-150 (684-2910) | 1:28‡ (18-73) | 1:15 (9.2-46.6) | 1:125‡ (52.3-∞) | 1:5.5 (3.4-14.7) | 1:3.9 (2.4-9.6) |
Fetal hemorrhage | 1:15,4004-150 (5240-∞) | 1:385 (130-∞) | 1:123 (41.7-∞) | 0 | 1:44 (15.0-∞) | 1:31 (10.6-∞) |
Population (n) . | ||||||
---|---|---|---|---|---|---|
HPA-1a | NK | Negative | Negative | Negative | Negative | Negative |
HLA-DRB34-1500101 | NK | NK | Positive | NK | Positive | Positive |
Anti–HPA-1a | NK | NK | NK | Negative | Positive at any time | Persistently positive antenatally |
Event | 25,379 | 387 | 123 | 341 | 46 | 32 |
HPA-1a negativity | 1:40 (36.7-42.8) | |||||
HPA-1a alloimmunization | 1:3474-150(282-451) | 1:8.4 (6.9-12.1) | 1:2.8 (2.3-3.7) | |||
Thrombocytopenic infant4-151 | 1:3364-150 (250-509) | 1:8.6‡(6.5-12.7) | 1:4.9 (3.6-7.6) | 1:21‡ (13.4-46.3) | 1:2.1 (1.6-3.0) | 1:1.8 (1.4-2.7) |
Severe thrombocytopenia4-153 | 1:11004-150 (684-2910) | 1:28‡ (18-73) | 1:15 (9.2-46.6) | 1:125‡ (52.3-∞) | 1:5.5 (3.4-14.7) | 1:3.9 (2.4-9.6) |
Fetal hemorrhage | 1:15,4004-150 (5240-∞) | 1:385 (130-∞) | 1:123 (41.7-∞) | 0 | 1:44 (15.0-∞) | 1:31 (10.6-∞) |